Sobi North America News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome

Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesDrug administrationSobi investor relations teamNorth americaNorth americanSwedish orphan biovitrumFast trackMacrophage activation syndromeSobi mediaInfection with usePrescribing informationSobi north americaMiddle east

Sobi to present new myelofibrosis data at the ASCO 2024 Annual Meeting

Sobi to present new myelofibrosis data at the ASCO 2024 Annual Meeting
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSobi investor relations teamDrug administrationAmerican society of clinical oncologyNorth americaNorth americanSwedish orphan biovitrumAmerican societyClinical oncologyAnnual meetingSobi mediaImportant safetyPrescribing informationSobi north americaMiddle east

Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome

Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesDrug administrationSobi investor relations teamTrack designationMacrophage activationNorth americaNorth americanSwedish orphan biovitrumFast trackMacrophage activation syndromeSobi mediaInfection with usePrescribing informationSobi north americaMiddle east

Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia

Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesBritish columbiaBob mclayBrian castelliCharlesh liSobi investor relations teamHealth canadaHealth canada approvesUniversity of british columbiaNational organization for rare disordersTwo indicationsNorth americaNorth americanSwedish orphan biovitrumConsultant hematologist

Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia

Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesBritish columbiaBob mclayCharlesh liNational organization for rare disordersHealth canadaSobi investor relations teamUniversity of british columbiaNorth americaNorth americanSwedish orphan biovitrumConsultant hematologistVancouver general hospitalClinical associate professorWestern europe